Skip to main content
Home

the global voice for women's health

Switch Language
  • English
  • Français
  • Español
  • About us show further links
    • About us
    • What we do
    • FIGO Programmes
    • FIGO Divisions and Committees
    • Our strategy: 2021–2030
  • Our Members show further links
    • FIGO Members
    • Benefits of Membership
    • FIGO Women’s Awards 2025
  • Events show further links
    • FIGO 2025 World Congress
    • FIGO 2023 World Congress
    • FIGO Webinars
    • FIGO and Chien-Tien Hsu Fellowship
  • News show further links
    • FIGO News
    • FIGO Blog
    • FIGO Press Releases
    • FIGO Monthly Newsletter
    • Celebrating 70 Years of FIGO: A legacy of advancing women's health
  • Resources show further links
    • FIGO Knowledge Hub
    • FIGO Resources
    • IJGO - International Journal of Gynecology & Obstetrics
    • FIGO Statements
    • Fistula Resource Hub
    • FIGO Cancer Staging Collection
  • About us
  • Contact Us
  • Work for FIGO
  • Donate to FIGO Programmes

Breadcrumb

  • Home
  • FIGO Statements

FIGO Statements

FIGO regularly issues statements and joint statements.

  • Adolescence and Youth Health
  • Adolescent Health
  • Menopausal Age
  • Reproductive Age
  • Breast Health
  • FIGO World Congress
  • FIGO Regional Congress
  • Events
  • FIGO CPD
  • FIGO Global Webinar
  • Health Systems Strengthening
  • Infections During Pregnancy
  • Well Woman Health
  • Technology
  • Newborn Health
  • Surgery
  • STIs
  • Safe Abortion
  • Refugees
  • Postpartum Hemorrhage
  • Oncology
  • Obstetric Fistula
  • NCDS
  • Environmental Health
  • Medical Ethics
  • Maternal Health
  • Healthy Ageing
  • Health for All
  • Gynaecology and Technology
  • FGM
  • Fertility
  • Family Planning
  • Women's Health Rights
22/10/2021

FIGO welcomes Benin’s new law to address preventable maternal deaths and disability by improving access to safe abortion

Read More
19/10/2021

Conscientious objection: a barrier to care

Read More
18/10/2021

Uterine balloon tamponade for the management of postpartum haemorrhage within health systems

Read More

Improving Access to Abortion Beyond 12 Weeks of Pregnancy

Read More

Addressing Barriers to Safe Abortion

Read More

Abortifacient Product Quality

Read More

Post-Abortion Contraception, including Long-Acting Reversible Contraceptives

Read More
30/06/2021

Joint statement of recommendation for the use of uterotonics for the prevention of postpartum haemorrhage

Read More

Pagination

  • Previous page <
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Next page >
Home

Find out more

  • About us
  • Resources
  • Divisions & Committees
  • FIGO Programmes
  • Contact us

Other Information

  • Vacancies
  • Work for FIGO
  • Terms & Conditions
  • Privacy Notice & Cookies
  • Accessibility

Follow us

  • facebook
  • instagram
  • twitter
  • youtube
© 2025 FIGO Website design by Fat Media